BRAF and cancer: Much effort has been devoted to exploring the molecular mechanisms underlying this role of BRAF V600E in recent years, leading to a general consensus that, through aberrantly activating the MAPK pathway, BRAF V600E alters the expression of key genes that are involved in cancer cell activities and tumor pathogenesis [2].